A new drug developed by Norvartis, LCZ696, showed surprising success in recent clinical trials. The drug has the potential to help individuals with chronic heart failure live longer, more comfortable lives.
As Ebola continues to make headlines, doctors, researchers, and epidemiologists alike search for answers about this mystery disease and its tremendous virulence.
For opioid addicts, it’s all too tempting to give the drug one more try. A heroin euphoria—temporary warmth, dulled senses, painlessness—slips away after 10 or 15 minutes, abandoning the addict to several days of withdrawal symptoms that could fade with the easy pleasure of one more dose.
Herpes Simple Virus Type II is capable of eluding vaccines that utilize the body’s adaptive immune response. Yale Professor of Immunobiology Akiko Iwasaki and her research group have discovered a network of immune cells that provides sustained protection at the site of infection, suggesting a more effective approach to vaccine development.
Surgeons in Australia have successfully performed heart transplants using “dead” hearts. The surgeons have been able to revive these hearts using a “heart-in-the-box” device.
Unexpected events in Cassie Tarleton’s academic career have led her to public health, specifically to serving the health needs of Asian American communities.
Recent studies in the field of microbiology have overturned prior beliefs on the mechanism of action of antibiotics. These findings hold promise for the future development of antibiotic drugs for combatting the rise in superbugs worldwide. But first, the mystery surrounding antibiotics must be solved.
Recent research on the worm C. elegans reveals a connection between the gene SKN-1, proline, and fat accumulation. In the future, miracle drugs may target these genes to prevent weight gain, even in the condition of a high-sugar diet.
Amputees have reported that mind-controlled prosthetics allow them to “feel” their hands for the first time since their amputation. These prosthetics use sophisticated algorithms to relay sensory information to the brain, as well as implanted electrodes in the arm to provide refined, natural movement actuated by the mind of the wearer.
How do the mind and body interact? Yale alumnus Dr. David Spiegel (YC ’67) draws upon his experiences in both philosophy and psychology to answer this question.